RESOLUTE ONYX China Single Arm Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 591 participants.

Also called NCT03471845

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 591 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03471845
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03471845. Allocation not applicable; no masking; primary purpose treatment. Start 2018-03-30 (actual); primary completion 2021-02-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RESOLUTE ONYX China Single Arm Study
Condition
Ischemic Heart Disease
Condition
Stenotic Coronary Lesion
Condition
Cardiovascular Diseases
Condition
Arteriosclerosis
Intervention (Device)
Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct03471845
Content hash
b3143bf53d474f216cdd40a91bf89dbfad27e7e638b8ae8c60fd57c0a87c0360